Radiation Oncology/Bladder/RTOG Bladder

From Wikibooks, open books for an open world
< Radiation Oncology‎ | Bladder
Jump to: navigation, search

Bladder: RTOG OPEN TRIALS
Number Title
09-26 A Phase II Protocol For Patients With Stage T1 Bladder Cancer To Evaluate Selective Bladder Preserving Treatment By Radiation Therapy Concurrent With Cisplatin Chemotherapy Following a Thorough Transurethral Surgical Re-Staging
07-12 A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
05-24 A Phase I/II Trial Of A Combination Of Paclitaxel And Trastuzumab With Daily Irradiation Or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery For Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer


Bladder: RTOG CLOSED TRIALS
Number Title Publication
02-33 A Phase II Randomized Trial For Patients With Muscle-Invading Bladder Cancer Evaluating Transurethral Surgery And BID Irradiation Plus Either Paclitaxel And Cisplatin Or 5-Fluorouracil And Cisplatin Followed By Selective Bladder Preservation And Gemcitabine/Paclitaxel/Cisplatin Adjuvant Chemotherapy  
99-06 A Phase I/II Trial In Patients With Muscle-Invading Bladder Cancer Of Transurethral Surgery Plus Taxol, Cisplatin, And BID Irradiation Followed By Either Selective Bladder Preservation Or Radical Cystectomy And Adjuvant Chemotherapy PMID 19100600
97-06 A Phase I/II Trial In Operable Patients With Muscle-Invading Bladder Cancer Of Transurethral Surgery And Cisplatinum/ BID Irradiation Followed by Either Selective Bladder Preservation Or Radical Cystectomy And Adjuvant Chemotherapy PMID 14529770
95-06 A Phase I/II Trial Of Transurethral Surgery Plus Induction Chemoradiotherapy Followed By Either Selective Bladder Preservation Or Radical Cystectomy As Determined By Initial Response And Operability In Patients With Muscle-Invading Bladder Cancer PMID 11110598
91-16 Pilot Study of the Quality of Life of Bladder Cancer Patients Being Treated on the Companion Protocol RTOG-8903  
89-03 A Phase III Trial To Study The Role of Neoadjuvant MCV Chemotherapy Combined With Transurethral Surgery Plus Cisplatin With Radiation Therapy For Selective Bladder Preservation In Patients With Muscle-Invading Bladder Cancer PMID 9817278
88-14 Phase I/II Study of Neoadjuvant Chemotherapy with MCV (MTX/CDDP/VBL) with Intraoperative Electron Beam Radiotherapy and Pre- and Postoperative External Beam Radiotherapy in Patients with Invasive Bladder Carcinoma  
88-02 Phase I/II Study of Neoadjuvant Combined Modality Treatment with Chemotherapy with MCV (MTX/DDP/VBL) plus Radiotherapy and DDP with Selective Bladder Preservation in Patients with Invasive Bladder Cancer PMID 8558186
87-05 Phase I/II Study of Radiotherapy and Hyperthermia in Patients with Selected Measurable Superficial Tumors PMID 8256760
87-03 Phase I/II Study of Combined Modality Therapy with DDP and Regional Hyperthermia in Patients with Malignancies of the Pelvis and Lower Abdomen  
86-08 Phase II Trial of WR-2721 Administered Before Protracted Fractionated Radiotherapy in Patients with Cancer of the Rectum, Cervix, or Bladder  
85-12 Phase II Study of Radiotherapy plus Chemotherapy with cis-Platinum for Stage B/C/D1 Carcinoma of the Bladder with Surgery for Treatment Failures PMID 8478228
83-08 Phase I/II Evaluation of Twice-Daily Fractional Radiotherapy for Locally Advanced Stage B/C/D Transitional Cell and Unresectable Squamous Cell Carcinoma of the Bladder PMID 3058657
81-10 Phase III Photon vs Mixed Beam Preoperative Radiotherapy for Stage B/C/D Carcinoma of the Bladder  
81-06 Phase III Randomized Comparison of Sandwich vs Standard Preoperative Adjuvant Radiotherapy in Stage B/C Bladder Cancer  
81-05 Phase I/II Misonidazole and Radiotherapy for Inoperable Bladder Cancer  
78-26 Photon Radiotherapy vs Pion Radiotherapy for Transitional Cell Carcinoma of the Urinary Bladder  
78-21 Phase I/II Radiosensitization with Misonidazole plus Radiotherapy for Bladder Cancer PMID 7180834
78-17 Phase II Study of Misonidazole plus Intraoperative Radiotherapy for Nonresectable Carcinomas  
78-16 Phase I-II Hyperthermia (43.5 Degrees Centigrade) Before and After Radiation Treatment for Human Tumors  
78-04 Adjuvant Radiotherapy before and after Surgery for Bladder Cancer PMID 3967204
77-05 Radiotherapy with Neutrons Alone or with Photons with or without Surgery for Urinary Bladder Cancer PMID 6375854
76-12 Preoperative or Postoperative Radiotherapy or Radiotherapy Alone for Clinical Stage B1 or B2 or C Bladder Carcinoma  
71-04 Comparison of Split-Course versus Continuous Radiotherapy for Carcinoma of the Head and Neck and Urogenital Regions PMID 4050737